These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 13685504)

  • 1. [Clinical studies of INH].
    BABA T
    Kekkaku; 1961 Aug; 36():508-11. PubMed ID: 13685504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies of INH-on the role of INH in combination with SM, PAS, and INH with special reference to the role of INH].
    OKA S
    Kekkaku; 1961 Aug; 36():512-20. PubMed ID: 13730558
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the use of vitamin B6 in the field of INH therapy].
    IRSKENS KJ
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 123():80-9. PubMed ID: 13717890
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the treatment of pulmonary tuberculosis with INH--ultrasonic aerosols].
    PICKROTH G
    Dtsch Gesundheitsw; 1960 Aug; 15():1668-73. PubMed ID: 13735486
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of lupus vulgaris with INH, PAS, and Tebamine.
    WEHNERT RA; MARCUSSEN PV
    Acta Derm Venereol; 1961; 41():461-70. PubMed ID: 14005585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoniazid (INH) prophylaxis].
    KLEINSCHMIDT H
    Med Welt; 1960 Sep; 36():1809-12. PubMed ID: 13756725
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of INH].
    KAWAMORI Y
    Kekkaku; 1961 Aug; 36():503-7. PubMed ID: 13751976
    [No Abstract]   [Full Text] [Related]  

  • 8. [On ambulatory longterm INH therapy. Part I. Therapeutic and clinical results].
    WERNER E; PHILIPP H; ZIESCHE K
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 121():587-98. PubMed ID: 13844037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Actual aspects of tuberculostatic therapy with INH].
    IWAINSKY H; KAUFFMANN GW
    Z Arztl Fortbild (Jena); 1960 May; 54():599-602. PubMed ID: 14406168
    [No Abstract]   [Full Text] [Related]  

  • 10. [On ambulant INH longterm therapy. Part II. Bacteriological results].
    WERNER E; PHILIPP H; ZIESCHE K
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 121():599-604. PubMed ID: 13844035
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On ambulant INH longterm therapy. Part III. Infectious hygiene results].
    WERNER E; PHILIPP H; ZIESCHE K
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 121():605-10. PubMed ID: 13844036
    [No Abstract]   [Full Text] [Related]  

  • 13. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical observations on the use of vitamin B-6 within the scope of INH therapy on the basis of clinical and experimental animal observations].
    TUENNERHOFF FK; SCHWABE HK; PETZOLD J
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 121():618-32. PubMed ID: 13839763
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.
    Ghiladi RA; Cabelli DE; Ortiz de Montellano PR
    J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.